Trabectedin for recurrent grade 2 or 3 meningiomas
- Author
- Dr. Iyad Alnahhas, Dr. Matthias Preusser
- Published
- Fri 28 Jan 2022
- Episode Link
- http://soc-neuro-onc.libsyn.com/trabectedin-for-recurrent-grade-2-or-3-meningiomas
Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.
